Table 1.
Proteomics quotients for the identification of potential FXR targets along with corresponding mRNA quotients.
Gray shading, FXR targets showing a difference at the protein level but not at the mRNA level after FXR ligand treatment. ND, mRNA levels below background level in the microarray analysis, i.e. not detectable.